Melbourne Genomics’ ground-breaking shared clinical system for genomics (GenoVic) is now ready for use in clinical genomic testing across Alliance members sites.
Victorian Clinical Genetics Services (VCGS) is the first laboratory to agree to use the GenoVic system as its primary tool for genomic interpretation. The system will support VCGS’ medical scientists to identify and report on the exact changes in a patient’s DNA driving their condition or targetable for treatment.
Further agreements on implementing GenoVic are in process with Alliance members Monash Health, AGRF and The Royal Melbourne Hospital.
“The product of more than three years of extensive investigation, prototyping and road-testing in real-world healthcare settings, our shared clinical data system is now ready for service,” said Melbourne Genomics’ Head of Data and Technology, Kate Birch.
“Our system establishes a single platform for clinical genomics, backed by two leading software vendors working in the genomics field.”
GenoVic is an integrated platform comprising DNAnexus for bioinformatic analysis, Agilent Alissa Interpret to support genomic interpretation, and a signature Melbourne Genomics-built orchestration engine to simplify and automate interaction between laboratories and each component of the system.
Chair of Melbourne Genomics’ GenoVic Project Control Group, David Hansen, said it was a significant achievement to have the system operational. “Full genomic testing brings an extra level of complexity. It’s taken some great collaborative work from health informaticians, medical scientists, clinicians, bioinformaticians, researchers and many other professionals from across the Alliance to make this work,” commented Dr Hansen, CEO of the CSIRO Australian e-Health Research Centre.
“We are all incredibly excited to see GenoVic at the point where it is now ready to support genomic testing in patient care.”